🇺🇸 Routine Lipid Management in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Routine Lipid Management (Routine Lipid Management) regulatory status in United States.

Marketing authorisation

FDA

Status: approved

Frequently asked questions

Is Routine Lipid Management approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Routine Lipid Management in United States?

Amgen is the originator. The local marketing authorisation holder may differ — check the official source linked above.